Tech Company Financing Transactions
Phasiq Funding Round
Private investors and Zell Lurie Commercialization Fund participated in a funding round for Phasiq. The financing was announced on 9/22/2015.
Transaction Overview
Company Name
Announced On
9/22/2015
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1600 Huron Pkwy. Building 520 2nd Floor 2398
Ann Arbor, MI 48109
USA
Ann Arbor, MI 48109
USA
Phone
Website
Email Address
Not Recorded
Overview
PHASIQ is commercializing high quality multiplex immunoassays with unprecedented time- and cost-savings. Our proprietary micropatterned phase separation (MPS ) technology makes PHASIQ the only company that provides a highly user-friendly immunoassay.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Francis Glorie
Chief Financial Officer
Jim Vincke
Chief Scientific Officer
Shuichi Takayama
VP - Marketing
Dunrie Greiling
VP - Product Management
John Dishinger
Browse more venture capital transactions:
Prev: 9/22/2015: haystagg venture capital transaction
Next: 9/22/2015: CloudFlare venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs